Alectinib in Children with Recurrent or Refractory ALK-positive ALCL: Phase 2 Trial in Both Children and AdultsTetsuya Mori,Masahiro Sekimizu,Reiji Fukano,Ilseung Choi,Kengo Takeuchi,Ukihide Tateishi,Takashi Terauchi,Akiko Kada,Akiko Saito,Ryuta Asada,Keizo Horibe,Hirokazu NagaiPEDIATRIC BLOOD & CANCER(2019)引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要